| Literature DB >> 30168181 |
Osman Yesilbas1, Esra Sevketoglu1, Mey Talip Petmezci1, Hasan Serdar Kihtir1, Meryem Benzer2, Cigdem Arikan3, Afig Berdeli4, Huseyin Baloglu5, Ozdil Baskan6.
Abstract
Entities:
Keywords: eculizumab, secondary sclerosing cholangitis; hemolytic uremic syndrome; therapeutic plasma exchange
Mesh:
Substances:
Year: 2018 PMID: 30168181 DOI: 10.1002/jca.21651
Source DB: PubMed Journal: J Clin Apher ISSN: 0733-2459 Impact factor: 2.821